This suggests that, rather than by increased SGPL1 expression, an S1P-degrading process augmented by elevated PLPP3 expression may, at least in part, be responsible for the lowered S1P content in the corpus callosum of patients with schizophrenia. Here, PLPP3 is linked to schizophrenia.